BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35050559)

  • 1. Cutaneous Lymphoid Hyperplasia With T-Cell Clonality and Monotypic Plasma Cells Secondary to a Tick Bite: A Hidden Critter and the Power of Deeper Levels.
    Cho WC; Gill P; Nagarajan P; Aung PP; Torres-Cabala CA; Curry JL; Ivan D; Lester L; Prieto VG
    Am J Dermatopathol; 2022 Mar; 44(3):226-229. PubMed ID: 35050559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features.
    Baldassano MF; Bailey EM; Ferry JA; Harris NL; Duncan LM
    Am J Surg Pathol; 1999 Jan; 23(1):88-96. PubMed ID: 9888708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of 55 cases of cutaneous lymphoid hyperplasia: reassessment of the histopathologic findings leading to reclassification of 4 lesions as cutaneous marginal zone lymphoma and 19 as pseudolymphomatous folliculitis.
    Arai E; Shimizu M; Hirose T
    Hum Pathol; 2005 May; 36(5):505-11. PubMed ID: 15948117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous borreliosis associated with T cell-predominant infiltrates: a diagnostic challenge.
    Kempf W; Kazakov DV; Hübscher E; Gugerli O; Gerbig AW; Schmid R; Palmedo G; Kutzner H
    J Am Acad Dermatol; 2015 Apr; 72(4):683-9. PubMed ID: 25617014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell-predominant lymphoid hyperplasia in a tattoo.
    Souza ES; Rocha Bde O; Batista Eda S; Oliveira RF; Farre L; Bittencourt AL
    An Bras Dermatol; 2014; 89(6):1019-21. PubMed ID: 25387518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous reactive B-cell lymphoid proliferations.
    Khalil S; Donthi D; Gru AA
    J Cutan Pathol; 2022 Oct; 49(10):898-916. PubMed ID: 35656820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential.
    Nihal M; Mikkola D; Horvath N; Gilliam AC; Stevens SR; Spiro TP; Cooper KD; Wood GS
    Hum Pathol; 2003 Jun; 34(6):617-22. PubMed ID: 12827617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous lymphoid hyperplasias.
    Gilliam AC; Wood GS
    Semin Cutan Med Surg; 2000 Jun; 19(2):133-41. PubMed ID: 10892716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent atypical lymphocytic hyperplasia following tick bite in a child: report of a case and review of the literature.
    Hwong H; Jones D; Prieto VG; Schulz C; Duvic M
    Pediatr Dermatol; 2001; 18(6):481-4. PubMed ID: 11841632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous lymphoid hyperplasia: a case report and brief review of the literature.
    Lackey JN; Xia Y; Cho S; Sperling LC
    Cutis; 2007 Jun; 79(6):445-8. PubMed ID: 17713147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
    Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
    Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated kappa and lambda light chain mRNA expression for the assessment of B-cell clonality in cutaneous B-cell infiltrates: its utility and diagnostic application.
    Magro C; Crowson AN; Porcu P; Nuovo GJ
    J Cutan Pathol; 2003 Sep; 30(8):504-11. PubMed ID: 12950502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoglobulin heavy chain gene rearrangement study in difficult cases of B-cell lymphoproliferative disorder].
    Wang Q; Li XQ; Zhu XZ; Zhu XL; Lu HF; Zhang TM; Zhou XY
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):296-301. PubMed ID: 20654151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous lymphoid hyperplasia and other lymphoid infiltrates of the breast nipple: a retrospective clinicopathologic study of fifty-six patients.
    Boudova L; Kazakov DV; Sima R; Vanecek T; Torlakovic E; Lamovec J; Kutzner H; Szepe P; Plank L; Bouda J; Hes O; Mukensnabl P; Michal M
    Am J Dermatopathol; 2005 Oct; 27(5):375-86. PubMed ID: 16148405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia.
    Goyal A; Moore JB; Gimbel D; Carter JB; Kroshinsky D; Ferry JA; Harris NL; Duncan LM
    J Cutan Pathol; 2015 Jan; 42(1):6-15. PubMed ID: 25384543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heavy multinodular cutaneous lymphoid infiltrates: clinicopathologic features and B-cell clonality.
    Ceballos KM; Gascoyne RD; Martinka M; Trotter MJ
    J Cutan Pathol; 2002 Mar; 29(3):159-67. PubMed ID: 11972713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous pseudolymphomas.
    Ploysangam T; Breneman DL; Mutasim DF
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):877-95; quiz 896-7. PubMed ID: 9631994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE.
    Brady SP; Magro CM; Diaz-Cano SJ; Wolfe HJ
    Hum Pathol; 1999 Feb; 30(2):130-6. PubMed ID: 10029439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous lymphomas and pseudolymphomas: newly described entities.
    Kazakov DV; Burg G; Dummer R; Kempf W
    Recent Results Cancer Res; 2002; 160():283-93. PubMed ID: 12079225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell cutaneous lymphoid hyperplasia representing progressive transformation of germinal center: a report of 2 cases.
    Kojima M; Sakurai S; Shimizu K; Itoh H
    Int J Surg Pathol; 2010 Oct; 18(5):429-32. PubMed ID: 18815203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.